resveratrol has been researched along with Dyslipidemia in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 10 (83.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Sashidhara, KV; Singh, SP | 1 |
| Buzzaccarini, G; Forte, G; Iervolino, M; Laganà, AS; Lepore, E; Unfer, V | 1 |
| Rabbani, N; Thornalley, PJ; Weickert, MO; Xue, M | 1 |
| Guerrero-Romero, F; Simental-Mendía, LE | 1 |
| Carrizzo, A; Civitillo, F; Damato, A; Franco, E; Marino, M; Pompeo, F; Puca, A; Santini, L; Traficante, A; Trimarco, V; Vecchione, C | 1 |
| Dash, S; Lewis, GF; Morgantini, C; Xiao, C | 1 |
| Hu, YJ; Liu, WX; Pan, QR; Ren, YL; Wang, G; Xu, Y; Zheng, JS | 1 |
| Breen, DM; Faubert, B; Giacca, A; Kwan, D; Moore, J; Nahle, A; Oprescu, AI; Park, E; Pereira, S; Tsiani, E | 1 |
| Beck, V; Jungbauer, A; Mueller, M | 1 |
| Houston, M | 1 |
| Choi, MS; Do, GM; Jeon, SM; Jung, UJ; Kwon, EY; McGregor, RA; Park, HJ | 1 |
| Amaral, TA; Franco, JG; Lima, NS; Lisboa, PC; Moura, EG; Oliveira, E; Passos, MC; Peixoto-Silva, N; Resende, AC | 1 |
3 review(s) available for resveratrol and Dyslipidemia
| Article | Year |
|---|---|
Lipid lowering agents of natural origin: An account of some promising chemotypes.
Topics: Animals; Biological Products; Dyslipidemias; Humans; Hypolipidemic Agents | 2017 |
Natural Molecules in the Management of Polycystic Ovary Syndrome (PCOS): An Analytical Review.
Topics: Ascorbic Acid; Dietary Supplements; Dyslipidemias; Fatty Acids, Omega-3; Female; Flavanones; Flavonoids; Follicle Stimulating Hormone; Humans; Hyperandrogenism; Inositol; Insulin Resistance; Luteinizing Hormone; Ovulation; Polycystic Ovary Syndrome; Resveratrol; Vitamin D; Vitamin E; Vitamins | 2021 |
New and emerging regulators of intestinal lipoprotein secretion.
Topics: Animals; Apolipoprotein B-100; Apolipoprotein B-48; Atherosclerosis; Bile Acids and Salts; Cholesterol; Chylomicrons; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Dietary Fats; Dipeptidyl-Peptidase IV Inhibitors; Drug Evaluation, Preclinical; Dyslipidemias; Exenatide; Fatty Acids, Nonesterified; Glucagon-Like Peptide 1; Glucagon-Like Peptide 2; Glucagon-Like Peptide-1 Receptor; Humans; Incretins; Insulin; Insulin Resistance; Intestine, Small; Lipoproteins; Microbiota; Peptides; Receptors, Glucagon; Resveratrol; Secretory Rate; Stilbenes; Triglycerides; Venoms | 2014 |
2 trial(s) available for resveratrol and Dyslipidemia
| Article | Year |
|---|---|
Reversal of Insulin Resistance in Overweight and Obese Subjects by
Topics: Adult; Blood Pressure; Body Mass Index; Carrier Proteins; Correlation of Data; Cross-Over Studies; Dietary Supplements; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Female; Glucose Metabolism Disorders; Glycosylation; Hesperidin; Humans; Inflammation; Inflammation Mediators; Insulin Resistance; Leukocytes, Mononuclear; Male; Obesity; Overweight; Pyruvaldehyde; Resveratrol; Tumor Necrosis Factor-alpha | 2021 |
Effect of resveratrol supplementation on lipid profile in subjects with dyslipidemia: A randomized double-blind, placebo-controlled trial.
Topics: Adult; Aged; Antioxidants; Dietary Supplements; Double-Blind Method; Dyslipidemias; Female; Humans; Lipids; Male; Middle Aged; Resveratrol; Treatment Outcome; Young Adult | 2019 |
7 other study(ies) available for resveratrol and Dyslipidemia
| Article | Year |
|---|---|
Resveratrol improves vascular function in patients with hypertension and dyslipidemia by modulating NO metabolism.
Topics: Acetylcholine; Biopterins; Dyslipidemias; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; NF-E2-Related Factor 2; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Resveratrol; Stilbenes; Superoxide Dismutase; Vasodilation | 2013 |
Resveratrol prevents hepatic steatosis and endoplasmic reticulum stress and regulates the expression of genes involved in lipid metabolism, insulin resistance, and inflammation in rats.
Topics: Animals; Diet, High-Fat; Dyslipidemias; Endoplasmic Reticulum Stress; Gene Expression; Inflammation; Insulin Resistance; Lipid Metabolism; Liver; Male; Non-alcoholic Fatty Liver Disease; Phytotherapy; Plant Extracts; Rats, Sprague-Dawley; Resveratrol; Stilbenes | 2015 |
Resveratrol prevents insulin resistance caused by short-term elevation of free fatty acids in vivo.
Topics: Animals; Biomarkers; Blood Glucose; Disease Models, Animal; Dyslipidemias; Emulsions; Fatty Acids, Nonesterified; Female; Glucose Clamp Technique; I-kappa B Kinase; I-kappa B Proteins; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Liver; Muscle, Skeletal; NF-KappaB Inhibitor alpha; Phospholipids; Phosphorylation; Rats, Wistar; Resveratrol; Serine; Soybean Oil; Stilbenes; Time Factors; Up-Regulation | 2015 |
PPARα activation by culinary herbs and spices.
Topics: Apigenin; Chalcones; Dyslipidemias; Humans; Luciferases; Plant Extracts; Plants; Plasmids; PPAR alpha; Resveratrol; Spices; Stilbenes; Transcriptional Activation | 2011 |
The role of nutraceutical supplements in the treatment of dyslipidemia.
Topics: Atherosclerosis; Dietary Fats; Dietary Supplements; Dyslipidemias; Humans; Lipoproteins; Lipoproteins, VLDL; Oxidative Stress; Pantetheine; Resveratrol; Stilbenes; Tocotrienols; Triglycerides; Vascular Diseases; Vasodilator Agents | 2012 |
Resveratrol ameliorates diabetes-related metabolic changes via activation of AMP-activated protein kinase and its downstream targets in db/db mice.
Topics: Adiponectin; AMP-Activated Protein Kinases; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Dietary Supplements; Dyslipidemias; Glucose Transporter Type 4; Glycated Hemoglobin; Glycogen; Insulin; Insulin Secretion; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Muscle, Skeletal; Resveratrol; Rosiglitazone; Stilbenes; Thiazolidinediones; Triglycerides | 2012 |
Resveratrol attenuates oxidative stress and prevents steatosis and hypertension in obese rats programmed by early weaning.
Topics: Animals; Antioxidants; Blood Glucose; Dyslipidemias; Fatty Liver; Female; Glutathione Peroxidase; Hyperphagia; Hypertension; Insulin Resistance; Liver; Obesity; Oxidative Stress; Rats; Rats, Wistar; Resveratrol; Stilbenes; Superoxide Dismutase; Thiobarbituric Acid Reactive Substances; Weaning | 2013 |